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0. Abstract 
 
Colorectal cancer is the third leading cause of cancer death worldwide with nearly 150.000 
new cases diagnose annually. New therapies have been developed for the last years 
targeting different proliferation and survival signalling pathways but few advances have 
been done to avoid relapse in patients. Cancer stem cells are proposed as the main 
mechanism of resistance in current therapies. These cells have been described as a subset 
among all the tumour cell populations which have stemness properties such as self-renewal 
and differentiation capabilities. These features allow them to survive after antitumor 
treatments and regenerate the entire tumour mass. Also, cancer stem cells have been 
proposed as the responsible of metastasis.  
Inflammation in colorectal cancer is a sign of poor prognosis and it has been proposed as the 
main driver of the tumour progression. Its relation with cancer stem cells has not been 
classified yet but pro-inflammatory molecules such as TNF-α or IL-1B are able to activate 
cancer stem cells-related signalling pathways such as Wnt or Notch pathways. Granzyme-A, 
a protease released by immune cells, is involved in implication during like bacterial sepsis or 
arthritis. Our preliminary data indicate it is involved in development of colorectal cancer.  
The current study analyse the implication of Granzyme-A in the activation of CSCs during 
inflammation-associated colorectal cancer in a mouse model. 
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0. Resumen 
 
El cáncer colorectal es la tercera causa de muerte por cáncer en todo el mundo con cerca de 150.000 
de nuevos casos cada año. Durante los últimos años se han desarrollado nuevas terapias para tratar 
este tipo de cáncer pero relativamente pocos avances se han conseguido debido a la alta recurrencia 
en los pacientes. Las células madre tumorales se han propuesto como una de las principales 
explicaciones para esta alta recurrencia. Estas células se han descrito como un tipo de población 
celular dentro de la heterogeneidad de un tumor que presentan unas características similares a 
células madre encontradas en tejidos como la capacidad de autorenovación y la capacidad de 
diferenciación. Estas características las hace únicas para mantener la integridad del tumor y 
conseguir superar las actuales terapias antitumorales. Además, se han propuesto que son las 
responsables de la metástasis tumoral. 
La inflamación en cáncer colorectal es un signo de mal pronóstico y se ha propuesto como 
uno de los principales motores de la progresión tumoral. Su relación con la aparición de 
células madre tumorales aún no está clara del todo pero moléculas proinflamatorias como 
TNF-α e IL-1B son capaces de activar rutas de señalización intracelular relacionadas con 
células madre como las rutas de Wnt o Notch. La Granzima-A, una proteasa liberada por las 
células inmunes, está bajo estudio debido a su implicación en enfermedades inflamatorias 
como la sepsis bacteriana o la artrosis. Estudios preliminares de nuestro laboratorio indican 
que está involucrada en el desarrollo de cáncer colorectal. 
El presente estudio analiza la implicación de la Granzima-A en la activación de las células 
madre tumorales durante el desarrollo de carcinoma colorectal asociado a inflamación en 
modelo murino.  
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1. Introduction 
 
CANCER STEM CELLS 
The first time scientific community heard about cancer stem cells was around mid-
1800’s. “The only point on which I lay stress is that the cause of the subsequent tumour is to 
be sought in a fault or irregularity of the embryonic rudiment” Julius Cohnheim, 1889. With 
this statement, Julius presented to the scientific community a new way to understand 
cancer, the cancer stem cell theory (Conheim 1867). However it took over a hundred years 
to see the first evidence of this theory in a seminal paper from Lapidot (Lapidot T 1994). 
It is well known that tumour cells within a tumour mass are very heterogeneous, 
overall in solid tumours, in terms of morphology, metabolism, proliferative rate, ability to 
metastasise and other features. This heterogeneity has been proposed for many years as an 
evident consequence of the genome instability and genetic reorganization produced in 
cancer cells. However, Lapidot et al. and a few years later Bonet et al., showed that these 
different cells found within a tumour did not have the same ability to produce tumours in 
mice (Lapidot T 1994, Bonnet D 1997). In these studies, different populations were identified 
based on the expression of different CDs (CD34 and CD38). The different populations were 
isolated using flow cytometry sorting and injected in NOD/SCID mice (severe combined 
immunodeficient mice) at the same cell concentration. After few weeks, just one particular 
cell population, CD34+ and CD38-, was able to produce tumours. After this discovery, 
researchers’ attention was attracted again and cancer stem cell theory was put on the table 
and reviewed carefully. 
Cancer stem cells theory 
Cancer stem cell (CSC) hypothesis assumes that tumours are organised hierarchically, 
analogous to a normal tissue. In this cellular structure, CSCs would be on the top and 
through differentiation, other cell types would emerge.  
The previous theory, the stochastic model or clonal evolution, describes 
heterogeneity in tumours as a consequence of high speed growing in tumour cells. As all of 
them are considered equal in terms of proliferation and tumour-forming potential, all 
different populations should have the same capability of initiating tumours. However, as 
Lapidot and Bonnet described, tumours might not be just a cluster of cells which grow 
quicker than other ones. Some cancer cells have the intrinsic ability to create an entire 
tumour mass with all the different populations meanwhile others only can divide 
themselves. Both models are shown in Image 1.  
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In normal tissues, three different populations can be found regarding their 
differentiation state: stem cells, progenitor cells and mature cells. Stem cells are low 
proliferative cells which have the potential of differentiating into any cell of the tissue; 
although they are a minor population, they are able to divide throughout the lifespan of the 
organism. Progenitor cells come from the stem cells and have a lower differentiation 
potential. They grow faster than stem cells but do not have an “infinitive” division capability. 
Finally, mature cells are the descendants of the progenitor cells and have no differentiation 
potential. Dying mature cells are replaced by new-born mature cells derived from 
progenitors, so then stem cells are responsible of the maintenance of the tissue. CSC model 
propose that tumours are equally organised than normal tissues. CSCs would be the 
responsible of maintaining all the tumour populations and would be able to divide 
themselves and survive at least as much as the normal stem cells.  
CSCs have two main characteristics that are vital in the maintenance of the tumour: 
self-renewal and differentiation capabilities. These features are share with normal stem cells 
and actually define themselves as stem cells. Self-renewal capability is the ability of stem 
Figure 1. Tumour heterogeneity models. A) Clonal evolution model. High proliferative and genomic instability result in a 
large number of cells differing in genotype and thus phenotype. The best fitted cells are selected by Darwinian processes 
to generate clonal variants of the tumours. B) CSC model. CSC population is capable to unlimited number of divisions. 
Tumour heterogeneity results from existence of phenotypically diverse populations of different stages of cell maturation 
(Fulawka L 2014).  
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cells to produce daughter cells with the same characteristics as the parental cells. In this 
way, stem cell population is continuously renovating itself and never disappears. That 
feature is vital in order to keep a residual stem cell niche within the tissue and, in the case of 
the CSCs, to survive against antitumor mechanisms. In the division process, stem cells also 
generate other daughter cell types which have different features and lack of self-renewal 
capability, the cancer mature cells. This process is called cell differentiation (Fulawka L 
2014). The term “stemness” has been adopted to denote both characteristic that define 
CSCs as well as normal stem cells.  
Signalling pathways implicated in CSC development 
The signalling pathways implicated in self-renewal and differentiation processes have 
been investigated for many years in order to elucidate the mechanisms by CSCs survive and 
keep the stemness. Notch, Hedgehog (Hh) and Wnt pathways are proposed as the best 
candidates to maintain the stemness and they likely are the most crucial for the tumorigenic 
potential of CSCs (Takebe N. 2015). Notch signalling, similar to the Wnt and Hh pathways, is 
a primordial, evolutionarily conserved cell-fate-determination pathway that has a great 
relevance in biology, from angiogenesis to CSCs or tumour immunity. It is involved in the 
communication between contiguous cells. The signalling pathway is show in Image 2. This 
pathway can be activated with 5 canonical ligands (DLL1, DLL2, DLL3, Jagged1 and Jagged2) 
which interact with 4 receptors (Notch1-4). Some clinical trials are underway to inhibit this 
pathway as it has been related to poor prognosis in cancer. Hh signalling pathway controls 
tissue polarity, patterning maintenance and stem-cell maintenance during the embryonic 
development. Hh is a protein which is released from a cell through the transporter 
Dispatched after acylation. Released Hh binds to the receptor Ptch1 to initiate its signalling 
pathway, shown in Image 2. Hyperactivation of this pathway has recently been recognized to 
cause tumorigenesis in a wide variety of tissues and its inhibition has shown to inhibit 
epithelial-to-mesenchymal transition (discussed below). Finally, Wnt signalling pathway is 
involved in embryogenesis and tissue self-renewal. Wnt proteins consist of a family of 
glycoproteins that serve as ligands for Frizzled (Fz), a transmembrane receptor. Fz receptors 
signalling converge in the transcription factor β-catenin, which is able to translocate into the 
nucleus thanks to the receptor signalling. Deregulation of this pathway have been associated 
to cancer and CSC activity, and β-catenin has been descripted to be necessary to maintain 
the CSC phenotype (Takebe N. 2010, Takebe N. 2015). 
CSCs origin and epithelial-to-mesenchymal transition 
In several kinds of cancer, CSCs have been proposed to originate from normal stem 
cells through tumour transformation (Sell 2004). However, some publications for over last 
decade have revealed than differentiated epithelial cancer cells can also serve as source of 
CSCs by reactivation of a latent developmental process called epithelial-to-mesenchymal 
transition or EMT. 
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EMT originally defined a process of cellular reorganization essential for embryonic 
development. This multi-step process results in the loss of cell-to-cell adhesion and the gain 
of invasive and migratory properties. During embryogenesis, EMT allows progenitor cells to 
migrate to distant sites within the embryo and generate the different tissues. Also, EMT is 
reversible in order to allow mesenchymal cells to differentiate and form the specific tissues 
and organs.  
EMT can also occur during tumorigenesis. It was first proposed as a contributor to 
cancer due to a remarkable concordance between the mesenchymal phenotype and 
characteristics observed in metastatic tumour cells. They need the ability to get out from 
tumour mass and extracellular matrix, migrate through the circulatory system and colonize a 
new site (Chang J. T. 2013). During the EMT, cells downregulate E-cadherin, a glycoprotein 
involved in cell adherence, and its loss has been linked to metastasis and poor prognosis. 
Wnt, Notch and Hh are known as EMT inducers as well as TGF-β cytokines and other niche 
factors. These factors have been related to cancer-associated fibroblasts and their co-culture 
with tumour cells induce EMT (S. Lamouille 2014). 
Clinical relevance of CSCs 
Increasing evidences support the role of CSCs during tumour recurrence. Traditional 
chemotherapy targets cells which high proliferation rate and so, CSCs might resist this kind 
of treatment thanks to their intrinsic characteristics, and regenerate the whole tumour. CSC-
related markers have been found to be predictors of clinical outcomes (Pece S 2010). High 
expression of ATP-binding cassette (ABC) superfamily of active drug transporters and 
multidrug-resistance proteins (MDRs) have been found in CSC population (Wong, 2011) . 
Also, we have already discussed the implication of EMT in the metastatic process and its 
relationship with CSCs.  
All these data suggest that targeting CSC would increase the favourable responses. 
Inhibitors of stemness signalling pathways are on clinical trials such as γ-secretase inhibitors, 
which inhibit the Notch pathway, or Porcupine inhibitors targeting the Wnt signalling 
pathway (Porcupine in involved in the synthesis of Wnt proteins) (Takebe N. 2015).  
Differentiation therapy emerged following the evidence of CSCs could come from 
normal stem cells. This kind of therapies tries to differentiate CSCs in order to force them to 
become mature cells. Mature cells do not have stemness characteristics and so, they would 
not be able to overcome traditional therapies (Sell 2004). 
COLORECTAL CANCER, INFLAMMATION AND CSCs 
Colorectal cancer 
Colorectal cancer (CRC) is the third leading cause of cancer death worldwide with 
nearly 150.000 new cases diagnoses annually and the 5-year relative survival rate is only 8% 
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despite diagnostic and therapeutic advances (Thomassen I et al, 2013). Sporadic CRC arises 
as a consequence of lacking homeostatic control of proliferation and apoptosis within colon 
epithelial cells, driving the cells towards immortality and increased proliferation. This 
deregulation is caused by genetic and epigenetic alterations such as p53, PI3K or EGFR. Wnt-
signalling pathway is the major driver of CRC initiation and progression. As we have already 
discussed, upon activation of the Wnt signalling pathway, β-catenin is translocate into the 
nucleus where it associates with transcription factors and different genes are activated. One 
of the most frequently Wnt-pathway related mutated genes in early transformation is APC 
(adenomatous polyposis coli). APC mutations generally result in defective β-catenin 
degradation and, as a consequence, the accumulation of β-catenin in the nucleus producing 
a perpetual transcription of Wnt target genes. Other genes associated to Wnt signalling 
pathway and commonly mutated in CRC are TP53 and the KRAS oncogene (Lise et al, 2015). 
All these events are grouped in three stages which are shown in Figure 3. In inflammation-
associated CRC, the progression starts on normal tissue which is affected by the 
environment or mutagens. These agents produce an injury which derives into a 
transformation of some cells in the colon crypts. Inflammation drives this stage in which 
signalling pathways are affected. These pathways evolve towards a low-grade adenoma, 
high-grade adenoma and finally a carcinoma, the final stage of the disease.  Tumour 
recurrence and metastasis are two critical survival-influencing factors of CRC so that, 
identification and targeting of CSCs is an active field in CRC research (Brenner et al., 2014).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Scheme of the CRC progression. On the top of the image, it is shown the key events of each stage on the 
development of inflammation-associated CRC. The progression goes from normal tissue to carcinoma, passing through 
aberrant crypt and adenoma, and it is marked in red the inflammatory molecules implied in this progression.  
ACF: aberrant crypt formation 
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Inflammation in CRC 
Tumour progression depends on the interaction between tumour cells and all the 
components of the tumour microenvironment including macrophages, B and T cells even 
fibroblasts. Tumours have the ability to remodel the stroma and establish a permissive 
microenvironment which includes growing factors and inflammatory cytokines that recruit 
inflammatory cells. Although chronic inflammation may be involved in all three stages of 
tumour development (initiation, promotion and progression), it appears to play a major role 
in promotion and progression (Karin, 2009).  
Inflammation is driven by soluble factors such as cytokines and chemokines which are 
produced by tumour cells as well as the cells which are recruited by them. Depletion of mast 
cells or macrophages resulted in a profound remission in intestinal polyps in mice confirming 
the implication of immune cells in the progression of cancer. Several inflammatory cytokines 
have been involved in colorectal carcinoma progression like TNF-α, IL-8 and IL-6 (Lidija 
Klampfer, 2013).  
Recently, it has been described a serine-protease protein family produced by immune 
cells called granzymes (Gzm) which could be a link between cellular immunity and 
inflammatory processes such as CRC.  
Cytotoxic mechanisms of the immune cells 
Granzymes are mainly expressed inside cytosolic granules within cytotoxic B 
lymphocytes (CTL) and Natural Killer cells (NK cells).  
CTLs and NK cells use IFN-γ, death cell ligands (TRAIL and FasL) as well as exocytosis 
of these granules in order to control intracellular pathogens and transformed cells. The 
granule exocytosis is a process leaded by the recognition of the immune cells and target 
cells, which produces the release of the granules. These granules contain perforins and Gzms 
(Martínez-Lostao et al, 2015).  
Perforin is a membrane-pore forming protein which is essential for the Gzm cytotoxic 
mechanism. Perforin produce pores which are not able to kill cells on their own but allow 
Gzms to enter into the cells (Voskoboinik I et al, 2015). Perforin-deficient mice lose the 
cytotoxic capability of their lymphocytes and cannot control the viral infection as much as 
wild type mice do. Also, its role in tumour control is being clarified. Actually, perforin-
deficient mice develop lymphoma spontaneously (Arias et al, 2014). 
On the other hand, Gzms are a serine-protease protein family located within 
cytotoxic granules of the NK cells and lymphocytes. There are 5 Gzms known in humans (A, 
B, H, K and M) and 10 in mice (A, B, C, D, E, F, G, K, M and N) (Ewen et al, 2011). GzmA and 
GzmB are the most abundant and better characterised. Each Gzm has different cut 
13 
 
  
specifications and substrates. GzmA and B in addition to perforin constitute one of the main 
mechanism in antiviral and antitumor activity (Pardo et al, 2009). 
GzmB can act in the extracellular medium independently of perforin, regulating 
processes such as inflammation, coagulation an aging (Pardo et al, 2007). Inside the cells, 
GzmB is able to cut a wide variety of substrate but mostly caspase 3 and Bid proteins. Once 
they are processed, these proteins are able to produce apoptosis in the cell.  
The role of the GzmA in the cytotoxic process is still in controversy. The original 
articles when GzmA was described as well as its cytotoxic capability used high concentration 
of the protein which is almost impossible to find physiologically. Also, GzmA from different 
animals were used in those experiments (Hayes et al, 1989). However, experiments which 
use Gzms and perforins from the same specie showed that GzmA was not able to kill target 
cell on the contrary to GzmB at low concentrations (Susanto et al, 2013). Although this 
controversy in the role of GzmA in cytotoxic events, its influence in the inflammation is more 
clear. GzmA is able to process pro-IL 1β as well as induce the release of IL-1β, TNF-α and IL-6, 
all pro-inflammatory cytokines. Confirming this role in inflammation, GzmA-deficient mice 
are more resistant to sepsis than wild type (Arias et al, 2014). 
Inflammation and CRC-associated CSCs 
All the CRCs produce a local inflammatory response in a high or low degree, which 
actually means that immune cells are infiltrated within the local environment and produce 
the inflammation. Studies with mouse models indicate that the elimination of cytotoxic 
lymphocytes CD8 reduce the aggressiveness of the colitis (an inflammatory colon disease) 
and the incidence of colitis-associated CRC (Philippe et al., 2006). Immune cells are a reserve 
of all these pro-inflammatory cytokines so their elimination contributes to a better 
prognosis. In fact, most of the carcinoma has a constitutive activation of transcription factors 
such as NK-κB and STAT3 (Ditsworth et al, 2004). 
Inflammation is a key step in the development of CRC and it has been demonstrated 
that pro-inflammatory cytokines in tumours predict a poor diagnostic. CSCs have been 
proposed as an explanation of this increase of the tumorigenesis. Li Y et al found that TNF-α 
was able to activate the Wnt signalling pathway through the activation of NK-κB, and its 
activation produced more amount of cancer-initiating cells (cells which are able to create a 
tumour mass and are related to CSC characteristics). These authors found that this cytokine 
can influence in the development and invasion of tumour cells by CSC renewal and EMT 
activation. IL-1B produced the same effects due to the fact that this cytokine activated the 
same pathway (Li et al, 2012). Also, indirect evidences of the relation among CRC and 
inflammation come from epidemiologic studies, in which administration of non-steroidal 
anti-inflammatory drugs is inverse related with the incidence even mortality (Flossmann et 
al, 2007). 
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2. Antecedents and Objectives 
  
CSCs have been typically identified and isolated based on the expression of one or 
multiple cell surface markers associated to cancer stemness such as CD133, CD44 or 
different transcription factors associated to CSCs. Image 3 show the hallmark of CSCs and 
the goal in CSC identification and isolation. 
CD133 is also known as prominin-1. It belongs to a pentaspan transmembrane 
glycoproteins family which specifically localize to cellular protrusions. Although its function is 
unknown yet, it is believed to be associated with tumorigenesis and tumour progression. The 
up-regulation of CD133 in colorectal cancer correlates strongly with poor prognosis and 
synchronous liver metastasis (Spiegelberg et al, 2014).  
CD44 is the hyaluronic acid receptor. It has a role in facilitation of cell to cell and cell-
matrix interactions and in the assembly of growing factors on the cell surface; it presents 
cytokines and chemokines to their complementary receptors on the cell membrane. CD44 
has been used extensively as a CSCs isolating marker in so many cancers such as breast, 
prostate, pancreas and colorectal cancer. As few as CD44+ cells can promote tumorigenesis 
in mice and display stemness properties such as self-renewal and differentiation. Some 
contradictory papers can be found in the bibliography in order to validate this marker as a 
real CSC marker so controversy is still present (Jaggupilli et al, 2012).  
CD24 protein has been associated to CSC properties too. It is a small cell surface 
protein anchored by glycosyl-phosphotidyl-inositol and involved in cell-to-cell and cell-matrix 
interactions. CD24 was discovered in mice as a heat-stable antigen and was used as a marker 
to differentiate hematopoietic and neural cells before knowing its implication in cancer. 
CD24 expression in tumours has been associated with poor prognosis and increased 
metastasis (Jaggupilli et al, 2012).  
CD166 is another novelty cell surface marker used in the identification for CSCs in 
colorectal cancer.  Its expression has been pathologically correlated with aggressive disease 
and high-expressing cells isolated in tumours are able to generate tumorigenesis in mice at 
low numbers, a hallmark of a CSC population (Levin et al, 2011) 
In addition to cell surface markers, other features can be analysed in order to identify 
CSCs in tumours in general and in particular in colorectal cancer. One strategy is to identify 
transcription factors associated to pluripotency such as Oct3/4, Sox2 or Nanog. These 
factors were first descripted as the transcription factors necessary for induced pluripotential 
cells (iPS cells). Their expression can be detected in CSCs and it is a sign of poor prognosis in 
many types of cancer, including colorectal carcinoma, as well as of relapse, distant 
recurrence and chemoresistance (Amini et al, 2014)(Liu et al., 2013).  
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ALDH1 activity is one of the widest markers used to identify CSCs, from now named 
as ALDH activity. ALDH1 (aldehyde dehydrogenase) belongs to a family of dehydrogenases 
which are involved in detoxification processes. ALDH activity has been used to detect and 
isolate both cancer stem cells and normal stem cells. Immunostaining data show that rare 
epithelial cells at the base of the normal crypt express ALDH activity (normal stem cells in 
their stem cell niche). In cancer, this activity is not limited to the base of the crypt and that 
expression expands in the epithelia of the cancerous colon. As few as 25 primary colon 
cancer cells expressing high levels of ALDH are able to generate tumours in NOD/SCID mice 
confirming their CSC properties of these cells (Shenoy et al, 2014).  
Another marker typically used for the identification of stem cells, and later CSCs, is the ABC 
transporter activity, which can be analysed using the Hoechst 33342 expulsion test. This test 
has been used to evaluate the capability of cells of ejecting colorants thanks to their efflux 
Figure 3. Typical way to isolate and identify stemness markers. Cells with a high expression of one particular CSC-related 
marker are isolated by flow cytometry and injected into NOD/SCID mice at low number. If these cells are able to engraft, 
the marker analysed might be a CSC-related marker. 
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pumps. These pumps are ABC transporters involved in the excretion of diverse compounds 
and they are descripted as a detoxification mechanism. Cells with have a high expression of 
these transporters are commonly known as side population and are associated with 
stemness properties (Dean, 2009).  
IMPLICATION OF GRANZYME-A IN INFLAMATION AND COLORECTAL CANCER 
Although our data are not published yet, we have strong evidence that GzmA is 
involved in the development of inflammation-induced colorectal cancer. We use a mouse 
model of chronic inflammation leading colorectal cancer which consists in one first injection 
of a mutagenic compound, AOM, and one-week cycles of DSS treatment in drinking water (in 
detail description in Material and Methods chapter) which induce a chronic inflammation. 
These compounds together generate inflammation in colon which finally derivate into 
colorectal cancer. Our results have shown that GzmA-deficient mice have a lower incidence 
of cancer than wild type ones. Wild type mice show signs and symptoms of a high 
inflammation in colon and normal colon structure has completely destroyed after the 
treatment whereas GzmA do not show that signs.  
 
MASTER DISSERTATION OBJECTIVES 
 
In the light of these results, we proposed the hypothesis of GzmA was involved in the 
emergence and development of CSCs in inflammation-associated CRC. So that, we proposed 
the following main goal: to figure out the implication of GzmA in the development of 
colorectal carcinoma through the study of CSCs. Our results show how GzmA produce a 
higher tumour incidence and this project tries to unravel the molecular and cellular 
mechanisms involved in this process.  
To get this main goal, we proposed the following secondary objectives:  
1. Evaluate the presence of CD44, CD166, Nanog, Sox2 and Oct3/4 CSC-related markers 
in colorectal cancer mouse cell lines.  
2. Evaluate the correlation between these markers and other CSCs-associated features 
such as ALDH activity and Hoechst 33342 expulsion (ABC transporter activity) and 
chemoresistance. 
3. Development of in vitro cell cultures enriched in CSC population such as 3D cell 
cultures an chemoresistant cancer cell lines 
4. Evaluate the presence of CSCs during CRC development in vivo in WT and GzmA-
deficient mice. 
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3. Materials and Methods 
 
3.1 - MATERIALS 
3.1.1 – Cell lines  
The next CRC cell lines were used in this study: CT26 was obtained from N-nitroso-N-
methylurethane-induced colorectal carcinoma in BALB/c mice, and MC38 and PJ01 were 
obtained from DSS-and-AOM-induced colorectal carcinoma in C57Bl/6 mice. CT26 and MC38 
cell lines were gently donated by Dr. Ignacio Melero, Clinical University of Navarra. PJ01 cell 
line was generated in our lab following the DSS/AOM-induced colorectal cancer-induction 
protocol as described below. These cell lines grow as adherent cells and have similar 
morphology to epithelial cells (Wang M et al, 1995) (Eisenthal A et al, 1993).  
3.1.2 – Cell culture maintenance materials 
Dulbecco’s modified Eagle medium (DMEM) from Lonza (Germany) was used as 
culture medium for all the cell lines. Fetal bovine serum (FBS) was from the same 
commercial company. 
Cell culture flasks, 15 ml and 50 ml conical tubes (Falcon tubes), 96-well plates and the 
rest of disposable sterile material were provided by Corning Company (USA). 5, 10 and 50 ml 
pipettes were supplied by Corning too. Cryogenic tubes to freeze cells were provided by 
Nunc (Netherlands).  
L-glutamin, penicillin, streptomycin, dimethylsulfoxide (DMSO) and trypsin-EDTA were 
provided by Sigma (Spain). Paraformaldehyde (PFA) was obtained from Scharlau (Spain). 
Different powders to make the buffers such as calcium phosphate, calcium chloride or 
sodium chloride were provided by Panreac (Spain).  
3.1.3 – Antibodies and reagents used for CSCs analysis and sorting 
To measure the expression of CD44, CD166, Nanog, Sox2 and Oct3/4, antibodies 
against these proteins were used. These antibodies are conjugated with different 
fluorophores in order to measure the union to the targeted proteins by flow cytometry 
(fluorophores used shown in Table 1). As a negative control, IgG1 isotypes conjugated with 
the same fluorophores were used (REA control). All antibodies were provided by Miltenty 
Biotech (Germany). The protein Annexin V was expressed and purified in our lab and 
conjugated with the fluorophores APC and FITC. 7-AAD reagent was provided by 
InmunoStep. The fluorescence maximum emission peak of Annexin V-FITC protein is at 519 
nm while Annexin V-APC’s one is at 660 nm. 7-AAD’s is at 647 nm.  
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Antibody Fluorophore 
conjugated 
Excitation peak 
wavelenght 
(nm) 
Emission peak 
wavelenght 
(nm) 
Clon Isotype 
Anti-CD44 PE 565 573 REA664 IgG1 
Anti-CD166 APC 650 660 REA370 IgG1 
Anti-Nanog APC 650 660 REA297 IgG1 
Anti-Sox2 APC 650 660 REA320 IgG1 
Anti-Oct3/4 APC 650 660 REA622 IgG1 
Hoechst 33342 was provided by Sigma and its maximum emission peak is at 461 nm. The 
ALDEFLUOR kit (ALDH enzyme activity detection kit) was provided by STEMCELL 
Technologies. The kit contains the reagent ALDEFLUOR, ALDEFLUOR buffer, ALDEFLUOR 
DEAB, HCl and DMSO. The ALDEFLUOR reagent emits fluorescence at 488 nm. 
Sorting was performed using FACS Aria sorting flow cytometer (BD Bioscience) at the 
flow cytometry service at CIBA. 
 
 
 
 
 
 
 
 
 
3.1.4 – Mice strains and colorectal cancer induction materials 
Inbred C57Bl/6 (B6) and mouse strains deficient for Granzyme A (GzmA -/-) bred on 
the B6 background were bred at Centro de Investigación Biomédica de Aragón (CIBA). Their 
genotypes were periodically analysed as described (Pardo et al., 2008). Mice of 8-12 weeks 
of age were used in all experiments and were performed in accordance with and approved 
by the local animal care commission. 
DSS, dextran sodium sulphate, was provided by MP (Canada) and AOM, 
azoxymethane, was provided by Sigma. Syringes were from BD Bioscience (Spain) and cell 
strainer from Miltenyi Biotech (Germany).  
Animal maintenance was at CIBA Animal Care Services.  
3.1.5 – Tumour disaggregation reagents 
Kit contains Predigestion solution (1xHBSS containing 5 mM EDTA and 1 mM DTT) 
and Digestion solution made of 0.05g of collagenase D (from Roche), 0.05 DNAse I (from 
Sigma (Spain)) and 0.3g of dispase II (from Roche) all dissolved in 100 ml of PBS. 
 
 
Table 1. Technical information about antibodies used. Fluorophore conjugated, excitation peak wavelength, emission 
peak wavelength, hybridome clon and Isotype data are shown in this table. 
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3.1.6 – Other reagents 
3-(4,5-dimethylthiazol-e-yl)-2,5-diphenyltetrazolium bromide (MTT) was provided by 
Sigma (Spain). The commercial solution is at 5mg/ml. Methocel (methylcellulose) was 
provided by Sigma (Spain) for developing in vitro 3D cultures.  
3.1.7– Analysis software 
All cytometry data were analysed using the software Weasel (v1.6) and statistical analysis 
were performed using GraphPad Prism 5 Software. 
3.2 – METHODS 
3.2.1 – CELL CULTURE MAINTENANCE 
3.2.1.1 – Cell lines maintenance and manipulation 
All cell lines were cultured in 25 or 75 cm2 cell culture flasks depending on the necessity. 
The cell lines were cultured in DMEM medium supplemented with 10% of SFB, Glutamax 2 
nM (glutamin) and antibiotics (penicillin 100 U/ml; streptomycin (100 µg/ml), known as 
complete DMEM medium. Cell lines were subcultured every 2 or 3 days depending on the 
cell proliferation rate. Cells were detached using a mixture of Trypsin-EDTA for 5-10 minutes 
(5-10’). After the incubation, cells were resuspended in complete DMEM medium and 
centrifugated at 525 xg for 5’. After discarding the supernatant, all cells were resuspended at 
the desired concentration in complete DMEM medium and placed into the corresponding 
culture flask. Cultures were performed in an incubator at 370C, 5% CO2 and moisture 
saturated air. 
Cell manipulations were performed into a vertical laminar flow hood (Telstar Bio All), 
which allow us to work in sterile conditions. Hand-made buffers were sterilised using 0,22 
µm pore-size filters or using an autoclave depending on the stability of the reagents.  
3.2.1.2 – Determination of cell number and viability 
Cell counting and cell viability were determinated using a Neubauer haemocytometer and 
Trypan blue exclusion test. Trypan blue is a colorant able to get into the dead cells which 
have lost membrane integrity. To perform it, we mix an aliquot of the cell culture with the 
same volume of Trypan blue solution the blue and non-blue cells are count in the Neubauer 
chamber using an optical microscope (Nikon). 
3.2.1.3 – Cell freezing and thaw 
To freeze, cells were taken in a Falcon tube and were spun down 525 xg for 5’. After the 
centrifugation, supernatant was discarded and cells were resuspended in complete DMEM 
medium supplemented with 10 % of DMSO. Cell suspension was put into sterile freezing 
containers frozen at -80º C and subsequently stored in liquid Nitrogen.  
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To thaw, cell vial was taken out from the freezer and got warm little by little. As cell-
containing ice is being defrost, liquid was taken and added to a Falcon tube with complete 
DMEM medium. When all cells were added to the tube, it was spun down 525 xg for 5’; the 
supernatant is discarded and cells were resuspended in complete DMEM medium and 
cultured as described above.  
3.2.2 – ANALYSIS OF CSC-RELATED CELL SURFACE MARKERS AND TRANSCRIPTION FACTORS 
IN CELL CULTURES 
The analysis of the surface markers was performed using specific antibodies targeting the 
proteins described in the literature as CSC-related proteins. We used antibodies against 
CD44, CD166, Nanog, Sox2 and Oct3/4; CD44 and CD166 are extracellular proteins while 
Nanog, Sox2 and Oct3/4 are intracellular transcription factors and different protocols were 
used for each protein type.  
3.2.2.1 – Protein extracellular staining 
After trypsinization and cell count, 150.000 cells were taken and add them into wells of a 
96-well plate. The plate was spun down and cells are resuspended in 50 µl of PBS with 5% of 
FBS. Antibodies anti-CD44 and anti-CD166 were added diluted according to the optimised 
concentrations (CD44 at 1/200 and CD166 at 1/20) as well as 7-AAD and Annexin V (both at 
1/10). 7-AAD is a reagent that enters the dead cells with the plasma membrane damaged. 
This reagent allows us to identify those cells which have some damage in the membrane and 
so, they are dead, and those which are supposed to be alive with the membrane intact. 
Annexin V is a protein that binds phosphatidylserine (PS); PS is a lipid exposed on the outer 
plasma membrane as an early event on the apoptosis development, so the identification of 
this lipid allow us to discriminate early apoptotic cells which have the membrane intact yet 
(and so 7-AAD is not able to get into them) and living cells. As negative isotype controls, IgG1 
antibodies chains conjugated with APC and PE were used at the same concentration as the 
corresponding antibody. IgG1 correspond to the heavy chain of the antibodies so it is used as 
a measure of the non-specific joints. As proteins, antibodies can interact with other 
membrane proteins on the cells and fluorescence would be detected although there was not 
specific recognition; using the nonspecific region of these antibodies (heavy chains) linked 
with the same fluorophores, these nonspecific interactions can be detected and eliminated. 
Cells were incubated with the antibodies for 20’ at 4º C in order to reduce the nonspecific 
interactions. Afterwards, plate was spun down at 2.850 xg for 2’ and each well was 
resuspended in 100 µl of PBS with 5% of FBS, transferred to flow cytometer tubes and 
analysed using 4 colour flow cytometry in a Beckman Coulter GALLIOS flow cytometer. The 
cytometer is able to analyse each cell independently; as default, size and complexity are 
analysed for each cell but also, fluorescence can be measured. In this case, 4 fluorescence 
measures were analysed as well as size and complexity for each analysis. 
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3.2.2.2 – Protein intracellular staining 
After trypsinization and cell count, 150.000 cells were taken for each analysis and added 
into wells of a 96-well plate. The plate was spun down and cells were resuspended in 50 µl of 
PBS with 5% of FBS. 7-AAD and Annexin V were added to the wells as described above and 
cells were incubated in the fridge at 4ºC for 20’. Afterwards, the plate was spun down and 
cells were resuspended in 50 µl of PBS with 4% PFA. PFA crosslinks the proteins and fix the 
cells. The fixation is a key step to keep the proteins and the cell cycle in the same state 
during the staining but obviously, cells are not alive anymore after this step. Cells were 
incubated with PFA for 20’ at 4º C. After the incubation, the plate was spun down at 2.850 xg 
for 2’ and cells were resuspended in PBS with 5% of FBS to wash the PFA and were spun 
down again. Antibodies targeting Nanog, Sox2 and Oct3/4 were added then in 50 µl of PBS 
supplemented with 0.1% of Saponin. Saponin is a compound which permeates cell and 
nucleus membranes and so, antibodies can get into the cells and reach their targets. REA 
Control is used as the isotype negative control. Cells were incubated with the antibodies for 
45’ at room temperature. Then, the plate was spun down at 2.850 xg for 2’ to wash the 
antibodies and cells were resuspended in 100 µl of PBS with 1% of PFA. Cells were 
transferred to flow cytometer tubes and analysed using 4 colour flow cytometry in a 
Beckman Coulter GALLIOS flow cytometer. 
3.2.3 – ANALYSIS OF THE SIDE POPULATION, ALDH ACTIVITY AND ITS CORRELATION WITH 
EXTRACELLULAR AND INTRACELLULAR CSC-RELATED MARKERS IN CELL CULTURES 
3.2.3.1 – Side population analysis 
After trypsinization and cell count, 150.000 cells were taken in wells of a 96-well plate. 
Hoechst 33342 was added final concentration of 5 µg/ml and cells were incubated with the 
dye for 45’ at 37ºC. Hoechst 33342 is a dye which can attach to the DNA; to analyse the 
efflux pumps activity, all the DNA binding sites must be saturated in order to accumulate 
free dye in the cytosol. These conditions allow the dye to get into the cells and saturate the 
DNA joints. Once incubation was done, plate was spun down and cells were resuspended in 
100 µl of complete DMEM medium without Hoechst 33342. The plate was incubated for 45’ 
at 37º C. As the DNA is saturated with the dye, efflux pumps can throw the Hoechst 33342 
out the cell. Those cells which have a high expression of efflux pumps will be able to release 
more dye and then, a less stained cell population can be found using flow cytometry. This 
population is known as side population and it is related to CSC characteristics. After the 
incubation in complete DMEM medium without dye, the plate was spun down and cells 
were resuspended in PBS with 5% of FBS. Further analysis such as intracellular or 
extracellular staining can be performed after this protocol.  
3.2.3.2 – ALDH activity analysis 
To analyse the ALDH activity by flow cytometry, ALDEFLUOR kit was used. This kit includes 
ALDEFLUOR buffer, ALDFLUOR reagent, ALDEFLUOR DEAB reactive, HCl (concentrated at 2N) 
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and DMSO. ALDEFLUOR reactive must be activated as it is provided in inactive form by the 
commercial company. To activate the reagent, 25 µl of DMSO were added to the vial of 
lyophilised ALDEFLUOR reagent. After 1’, 25 µl of 2N HCl were added and it was mixed 
thoroughly. The mixture was incubated for 15’ at room temperature. After the incubation, 
the reagent was ready to be used.  
To analyse the ALDH activity, 300.000 cells were transferred into an eppendorf tube with 
1 ml of ALDEFLUOR buffer. 5 µl of activated ALDEFLUOR reagent was added and, after mixing 
well, 500 µl of the mixture were transferred into another eppendorf tube containing 5 µl of 
DEAB reagent was added previously. Both tubes are kept within an incubator for 45’ at 37 
ºC. ALDEFLUOR reagent is highly fluorescence and the background is too high to measure 
fluorescence differences properly. DEAB is an inhibitor of the ALDH enzyme so, in this way, 
each analysis tube has its own negative control in which DEAB reagent inactivates the 
enzyme ALDH and background fluorescence can be measured.  
After incubation with the ALDEFLUOR 
reagent, tubes were spun down at 525 xg for 
5’ and cells were resuspended in 100 µl of PBS 
with 5% of FBS to wash the ALDEFLUOR 
reactive. Finally, cells were spun down again 
and were resuspended in 200 µl of PBS with 
5% of FBS to their analysis by flow cytometry 
in 50 µl of PBS with 5% of FBS. Further analysis 
such as intracellular or extracellular staining 
can be performed afterwards.  
To analyse all the markers on the same 
cells, Hoechst 33342 staining protocol must be 
performed at first in order to preserve ALDH 
reagent fluorescence as much time as 
possible. After that, ALDH activity analysis 
protocol was performed. As cells are going to 
be split in two tubes on ALDH protocol, double 
amount of cells must be used at the beginning. 
After ALDEFLUOR staining, extracellular 
staining was performed, adding antibodies 
anti-CD44 and anti-CD166 as well as 7-AAD. 
Some experiments were done using only 7-AAD to distinguish living and dead cells due to 
the limitation of fluorescence filters which restrain the use of Annexin-V as additional cell 
death marker. 
 
Figure 4. Schematic diagram which summarise the ALDH 
activity analysis protocol. 
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3.2.4 – CELL SORTING USING ANTI-CD44 ANTIBODIES 
In order to analyse the differentiation and colony formation capabilities of potential 
CSCs, cells were sorted using a sorter flow cytometer. This equipment allows us to isolate 
different cell populations in different tubes or plates. Cells can be sorted according any 
characteristic analysed by the flow cytometer such size, complexity and, the most common, 
fluorescence staining.  
Cells were stained with anti-CD44 antibodies following the protocol to stain 
extracellular proteins. Intracellular protein staining cannot be used as a sorting tool due the 
fixation step what kill the cells.  
To sort cells, at least 1x106 cells must be stained following the extracellular protocol 
previously described. The basis of the technique is: in a previous flow cytometry analysis, 
sorting regions are selected; fluorescence measures of these regions are registered by the 
sorting software and cells with the same fluorescence are electrically charged positively. 
Cells with different fluorescence are charged negatively. Using electric fields, both cell 
populations can be separated in different tubes or added into different wells. Cells were 
sorting depending on their CD44 expression. Cells with high expression of CD44 are 
considered as CD44high and cells which have low expression are considered as CD44low. Both 
cell populations were sorted in different plates and analysed as described below. 
3.2.5 – DIFFERENTIATION ASSAYS 
CD44high and CD44low were incubated in different 12-well plates at 30.000 cells/ml 
and 10.000 cells/ml. Wells with 30.000 cells/ml were incubated for 48h and then, was 
analysed by flow cytometry. Wells with 10.000 cells/ml were incubated for 1 week and then, 
CD44 expression was analysed as the same way. 
3.2.6– CLONOGENIC ASSAYS 
100 cells per each population were added to a 24-well plate in 2 ml of complete 
DMEM medium and incubated at 37ºC. After 10 days, the number of colonies was analysed 
using violet crystal staining. Cells were incubated for 20’ at room temperature with violet 
crystal solution which contains 6% of glutaraldehyde. After the staining, solution was 
recovered from the wells carefully and the colorant excess is washed using PBS. Colonies are 
now counted and pictures were taken. 
3.2.7 – LIMITING DILUTION ASSAY 
Cells were sorted by flow cytometry but now one cell was collected per well in a 96-
well plate and incubated in complete DMEM medium for 2-3 weeks. If a single cell is able to 
create a colony, a white dot will be observed after the incubation. The numbers of the 
colonies formed are counted in each plate as well as the type of colony concerning its size.  
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3.2.8 – ENRICHMENT OF CSC POPULATION USING PACLITAXEL AND DOXORRUBICIN DRUGS 
3.2.8.1 - MTT assays 
To find out the IC50 of each drug (the drug concentration that inhibit cell 
proliferation at 50%) in each cell, MTT assays were used. On a 96-well plate, 5.000 cells were 
added in a 96-well plate and incubated in 50 µl complete DMEM medium overnight. The 
following day, drugs were added at different concentrations in 50 µl of medium. Cells were 
incubated with the drugs for 48h and afterwards, 10 µl of MTT (5 mg/ml) was added to each 
well and incubated at 37º C for 1h. MTT is reduced by living cells generating an insoluble 
compound known as formazan that accumulates inside living cells as a purple coloured 
aggregate. On this way, the proliferation rate in medium with different drug concentrations 
can be measured after 48h. After the incubation with MTT reagent, the plate was spun down 
at 2.850 xg for 30’, supernatant was discarded and cells were resuspended in 100 µl of 
DMSO in order to dissolve the formazan crystals. Once dissolved, absorbance was measured 
at 540 nm. 
3.2.8.2 – CSC marker analysis after the drug treatment 
The IC50 concentrations determinated in the previous experiments were used to 
enrich CSC population in cell lines. CSCs are supposed to be more resistant to drugs than 
differentiated cancer cells so they should be enriched after treating cell cultures with 
adequate concentrations of drugs.  
100.000 cells were added in a 12-well plate in 500 µl of complete DMEM medium. After 24h, 
drugs were added and incubated for 48h. Then, supernatant was transfer to an eppendorf 
tube and cells attached to the plate were trypsinised in order to take all the cells, living as 
well as dead cells (which would be floating in the supernatant). When all the cells (living and 
dead) were taken in an eppendorf tube, it was spun down at 525 xg for 5’ and cells were 
stained following the protocols previously described. As control, cells with no drugs were 
used. 
3.2.9 – PRODUCTION OF CHEMORESISTANT CELL LINES 
Chemoresistant cell lines to PTX and Doxorubicin were generated using CT26, MC38 
and PJ01 cell lines to find out if CSCs can reconstitute the starting cancer cell populations.  
To create chemoresistant cell lines, cells were cultured in the presence of drugs as it 
has been described (Dallas et al, 2011). IC50 was considered again as a reference; this was 
the starting concentration. Cells were treated for 48h with drugs and then, medium was 
replaced by a fresh medium. Cells were incubated in medium without drug until reaching the 
confluence; cells were subcultured and then, drug was added again. This procedure was 
followed at least for one month until cells were able to grow in the medium containing 
drugs. At this point, the length of drug treatment was increased to 4 days.  
25 
 
  
3.2.10 – DEVELOPMENT OF 3D IN VITRO CELL CULTURES 
This procedure is based on Methocel reagent (methylcellulose). Cells were added as 
drops in culture medium and methylcellulose on a Petri dish lid. When the lid was placed 
back on the Petri dish, drops did not fall down thanks to the high superficial tension created 
in the drop. As the drops were hanging, cells go down towards the bottom of the drop and 
were forced to stay together. If the cells have enough adhesion molecules, cells start to grow 
as a spheroid which actually is considered a 3D culture.  
The method was optimised to make 1.000-cell-containing spheroids. A mixture of 
Methocel, complete DMEM medium and cells was placed in a Falcon tube. The proportions 
(V/V/V) of these compounds were: 10% of cells in complete DMEM medium, 20% of 
Methocel and 70% of complete DMEM medium. 25 µl were placed on a Petri dish lid forming 
drops. Once all the volume was added, the lid was turned over and drops were incubated 
24h at 37ºC. The bottom of the Petri dish was covered with water in order to prevent 
evaporation of cell culture medium.  
Once the spheroids had been formed, the drops were taken out and added in a 96-
well plate. In order to analyse the CSC-related markers by flow cytometry, at least 50.000 
cells were needed so around 10 spheroids were added per well. Spheroids were trypsinised 
using 100 µl of Trypsin-EDTA for 10’ and individual cells were stained as described above. 
3.2.10 – AOM/DSS MOUSE COLORECTAL CANCER 
C57Bl/6 mice were treated with a single injection of AOM plus 3 DSS cycles for 56-60 
days. AOM is a carcinogenic agent which in combination with a potent inflammatory 
stimulus induces colorectal cancer in mice. DSS administrated in drinking water produces a 
chronic intestinal inflammation. The combination of a single AOM injection with 3 cycles of 
DSS in drinking water produces inflammation-induced colorectal cancer in mice. AOM is 
administrated at 10 mg/kg of weight per mouse in 100 µl of PBS and DSS is administrated 
dissolved in drinking water at 2,5% (V/V). Each DSS cycle is followed by a two-week rest cycle 
during which water does not contain DSS. The scheme of the process is shown in Figure 5. 
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3.2.11 – ANALYSIS OF THE INFLUENCE OF THE GRANZYME A IN THE CSCs MARKERS IN 
INFLAMATION-INDUCED COLORECTAL CANCER MOUSE TUMOURS 
GzmA-deficient (GzmA -/-) mice and WT mice were treated with the protocol 
described above for. After 56-60 days, mice were sacrificed in accordance with the local 
animal care procedures and tumours were extracted from the distal colon. Tumours were 
kept in complete DMEM medium and digested following a previously described protocol 
(Weigmann et al, 2007). Tumours were incubated with 5 ml of Predigestion solution for 20’ 
at 37 ºC under slow rotation (around 40 xg). Subsequently, pieces were passed through a 
100 µm cell strainer and smashed carefully on it. Then, pieces were incubated again with 5 
ml of Predigestion solution for 20’ at 37ºC under slow rotation and passed through the cell 
strainer. The remaining tissue is washed with 1x PBS and transfer to a tube containing 5 ml 
of Digestion solution. The tissue was incubated for 20’ at 37ºC under slow rotation and 
afterwards, passed through the cell strainer. This last step was done as many times as the 
tissue requires to be completely disaggregated. Once all the cells were recovered, the tube is 
spun down at 525 xg for 5’ and cells are resuspended in 5 ml of complete DMEM medium.  
  
Figure 5. Scheme of the AOM/DSS mouse colorectal cancer model. Mice were treated with a single injection of AOM plus 
3 DSS cycles for 56-60 days. Each DSS cycle is followed by a two-week rest cycle during which water does not contain DSS. 
AOM is administrated at 10 mg/kg of weight per mouse in 100 µl of PBS and DSS is administrated dissolved in drinking 
water at 2,5% (V/V). After 56-60 days, mice were sacrificed and tumours were extracted from the distal colon in order to 
analyse the CSC-related markers. 
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Figure 6. CD44, CD166, Nanog, Oct3/4 and Sox2 expression in CT26, PJ01 and MC38 cell lines. Cells were incubated with 
antibodies anti-CD44, anti-CD166, anti-Nanog, anti-Oct3/4 or anti-Sox2 and fluorescence was analysed using flow 
cytometry. Living cells were selected by 7-AAD exclusion. Results are shown as dot plots in which cell size and fluorescence 
intensities are shown. The vertical bars within each plot represent the fluorescence of the isotype negative control. Black 
numbers within each dot plot indicate the percentage of positive cells and red numbers indicate the mean of the fluoresce 
intensity.  
4. Results 
 
4.1 – EXPRESSION OF CD44, CD166 AND TRANSCRIPTION FACTORS (NANOG, SOX2 AND 
OCT3/4) IN COLORECTAL CANCER CELL LINES  
According to the bibliography, CD44 and CD166 are proteins whom expression is 
related to CSCs characteristics. Our first aim was to identify these markers in the in vitro 
models of colorectal cancer. Three different cell lines were used: CT26, MC38 and PJ01, and 
the CSC-related markers CD44, CD166 and the transcription factors Nanog, Sox2 and Oct3/4 
were analysed. Although these markers have been described as CSC-related markers, its use 
is still controversial. 
These markers were analysed by flow cytometry as described in 3.2.3 Materials and 
Methods. After optimizing the staining protocol, the results of representative experiments 
are shown in Figure 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CT26 
PJ01 
MC38 
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As shown in Figure 6, all cell lines expressed high amount of CD44. Almost all cells 
expressed CD44 but some differences were found between them. CD44 expression in CT26 
cells was higher than in PJ01 and MC38 cells. Also, huge differences were found in CD44 
expression in CT26 cell line. The difference between different cell populations was almost 2 
orders of magnitude, which means that some cells expressed 100 times more of CD44 than 
others. Regarding MC38 and PJ01 cells, expression levels were more homogenous than in 
CT26 cells.  
In contrast to CD44, CD166 expression was not observed in all cell lines. CT26 cell line 
had a few numbers of cells as well as PJ01; however, MC38 cell line showed a higher 
expression of CD166.  
Regarding transcription factors, some differences were found too. Nanog expression 
was easily detectable in all cell lines in contrast to Oct3/4 and Sox2. A little Oct3/4 positive 
population was found in CT26 cell line whereas PJ01 and MC38 cells showed a higher 
expression of this marker. Sox2 positive cells were almost not found in the three cell lines. A 
few positive cells were detected in CT26 cells but they were not found in PJ01 and MC38 cell 
lines. 
4.2 – CORRELATION OF CD44, CD166 AND TRANSCRIPTION FACTOR EXPRESSION WITH ALDH 
ACTIVITY AND/OR THE SIDE POPULATION  
After analysing marker expression in each cell line, we were interested in knowing if 
these markers correlated with other characteristics associated to CSCs such as high ALDH 
activity or high efflux pumps activity in cell membrane. To analyse this correlation, the 
protocol indicated in 3.2.3 Material and Methods was performed. The analysis scheme is 
shown in Figure S1 (Annex). As shown in Figure S1, living cells were selected by their cell size 
and complexity as well as by 7-AAD exclusion. On selected living cells, CD44, CD166 and 
Nanog expression, ALDH activity and Hoechst 33342 retention was analysed by flow 
cytometry. The correlation of the high expression of these markers with the rest of them 
was analysed by histograms using flow cytometry software. As anti-CD166 antibody was 
conjugated with the same fluorophore as anti-Nanog’s, their correlation with CD44 and 
ALDH was analysed independently. Figure 7 shows all these results in CT26 cell line and 
Figure S2 (Annex) shows the same results for the other cell lines. 
As shown in Figure 7, expression of the markers is quite similar to the results shown 
in Figure 6. The populations expressing high and low levels of each marker were gated and 
the rest of the markers were analysed. CD44 high-expressing cell population does not show 
big differences in comparison with low-expressing cell population. Regarding ALDH, some 
differences were found, overall in CD166 expression. Cells with high ALDH activity express 
more amount of CD166 than cells with low ALDH activity as the maximum peak 
displacement shows. Same differences were found regarding CD166 and Nanog expression; 
positive cells in both markers showed peak displacements in comparison with negative cells 
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Figure 7. Correlation between CD44, CD166 and Nanog expression with ALDH activity and Hoechst 33342 retention in 
CT26 cell line.  
A. Cells were incubated with antibodies anti-CD44, anti-CD166, anti-Nanog and ALDH activity detection kit and Hoechst 
33342 retention assays were used to analyse the correlation between all of these CSC-related markers. Living cells were 
selected by 7-AAD exclusion. The results for each marker are shown in dot plots within numbers which indicate the 
percentage of positive cells. For each marker, high and low-expressing population were selected with gates using 
specialised flow cytometry software and the rest of the markers were analysed over these selected populations by 
histograms. In red, it is shown the population which has a higher expression of one particular marker, and in black, the 
population which has a low expression. Within the dot plots, percentage of positive cells of each marker is shown.  
B. In parallel, cells were incubated with anti-CD44 and anti-Oct3/4 or anti-Sox2 in order to analyse the correlation between 
these markers. The results are shown as dot plots within numbers show the percentage of positive cells of each quadrant. 
The detailed protocol used in these experiments is descripted in Material and Methods 3.2.3 and the analysis scheme is 
indicated in Figure S1 (Annex).  
despite the fact that there were a few number of positive cells. These results indicate that 
CD44, CD166 and Nanog high-expressing cells show a high ALDH activity. 
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Although no differences were found between CD44 high-expressing and CD44 low-
expressing cells regarding CD166 expression, great differences were found between CD166 
high and CD166 low-expressing cells regarding CD44 expression. This apparent contradiction 
can be explained because of the number of the cells. Small CD166 positive cell population 
was found in contrast to the large CD44 high-expressing population. Within the CD44 high-
expressing population there must be some cells which express high amount of CD166 and 
other cells which have low expression of CD166. The fluorescence peak show the 
fluorescence of all the cells; as the CD44 high-expressing population is large, CD166 high-
expressing cells within this population are undercovered by CD166 low-expressing cells and 
as a result, no differences can be found. However, if CD166 high-expressing population is 
selected from the beginning, as it is smaller, differences can be found. 
Hoechst 33342 retention test contradicted our previous results as well as the results 
found in the literature. Cells with high amount of efflux pumps are able to release Hoechst 
33342 therefore a population with less Hoechst 33342 fluorescence can be identified by flow 
cytometry. This population has been related stemness characteristics and it is known as the 
side population (Dean, 2009). Hoechst 33342 fluorescence can be measured on two 
channels by a flow cytometer; the easiest way to find the side population is representing 
both channels in a dot plot as shown in Figure 7. A Hoechst 33342 low retention population 
was found as previously described (Mori et al., 2012). However, and as shown in Figure 7, 
Hoechst 33342- population express less amount of the other markers than its Hoechst+ 
counterpart. Some authors include efflux pumps inhibitors in the Hoechst 33342 retention 
assay such as verapamil. This efflux pump inhibitor blocks their function and therefore, 
colorants are kept inside the cells. Using cells treated with verapamil as control, we would be 
able to observe differences in the Hoechst Blue-vs-Hoechst 33342 dot plot and confirm the 
identity of the side population. Although verapamil was not available in our lab, ALDH buffer 
contains different efflux pumps inhibitors so we decided to test if this buffer could be useful 
to confirm the side population in our cell lines. As Figure 8 shows, the side population was 
enriched when ALDH buffer was not used confirming that the side population was properly 
identified. However, no positive results were found regarding the correlation with the other 
markers.  
The correlation of Oct3/4 and Sox2 expression with ALDH activity was not analysed 
due to the low number of positive cells found and CD166 expression was not analysed 
because of both antibodies were conjugated with the same fluorophore. So, only the 
correlation between CD44 and transcription factor expression was analysed. However, a few 
numbers of double CD44 and Oct3/4 or Sox2 positive cells was found, as shown in Figure 
7.B.  
Regarding the other cell lines, results are shown in Figure S2.A and S2.B (Annex) and 
are quite similar to the results found in CT26 cell line. Slight differences were found between 
MC38 CD44high and CD44low-expressing population. High expression of ALDH correlated with 
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a high expression of CD166 and slightly with CD44; Nanog expression correlates with both 
higher expression of CD44 and ALDH. Large CD166+ population was found as Figure 1 shows 
but their correlation with high expression of ALDH and CD44 was not clear. Regarding 
Hoechst 33342, the same contradictory results as in CT26 cell line were found.  
Results in PJ01 cells were found. In this cell line, ALDH activity correlated to CD44 and 
CD166 and also with Nanog expression. CD44 high expression slightly correlated with high 
expression of the other markers. The Nanog+ and Oct3/4+ populations have decreased a bit 
in these experiments in comparison with the results shown in Figure 6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Effect of efflux pumps inhibitors in the Hoechst 33342 retention assay in CT26 cell line. Cells were incubated with 
or without ALDH buffer during the Hoechst 33342 staining protocol and afterwards, the extracellular, intracellular staining 
and ALDH activity protocols were performed. The side population is identified in Hoechst Blue vs Hoechst 33342 dot plot as 
the population with less fluorescence. Numbers in the dot plots indicate the percentage of the side population cells. Side 
population and non-side population in the analysis without ALDH buffer was gated and CD44, CD166 and ALDH fluorescence 
was analysed as histograms. Red numbers within the histograms indicate the mean of fluorescence intensity in the side 
population and black numbers indicate the non-side population ones.  
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4.3 – ANALYSIS OF CELL DIFFERENTIATION AND COLONY FORMATION 
After analysing the expression and correlation of CSC-related markers by flow 
cytometry, we were interested in analysing other features associated to CSCs. The main 
characteristics of CSCs, which actually define them as CSCs, are self-renewal and 
differentiation capabilities. As described in detail in the Introduction, both capabilities allow 
CSCs to regenerate the tumour mass by renewing CSC population as well as its non-CSC 
counterpart. If one of these CSC-related markers is essential to define CSCs, a population 
enriched in this marker should show these features.  
In order to figure out and test this hypothesis, differentiation and colony formation 
assays were performed sorting the different populations found by flow cytometry. Flow 
cytometry allow us to get these populations using its tool named FACS. 
30.000 cells of CD44high and CD44low populations were isolated from each cell line 
using FACS in order to perform a clonogenic assay. Cells were incubated in complete DMEM 
medium for 1 week and a half and afterwards, the number of colonies was counted. Results 
from CT26 cell line are shown in Figure 9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Clonogenic assay using the CD44
high 
population (CD44+ in the Figure) and CD44
low
 population (CD44-) from CT26 
cell line. Cells were incubated with anti-CD44 antibodies and isolated by flow cytometry using cell sorting as it is indicated in 
Materials and Methods. Living cells were selected using 7-AAD exclusion and Annexin V staining. 100 cells of the 10% top or 
low CD44-expressing cells were collected in 24-well plate with complete DMEM medium and incubated for 10 days at 37ºC. 
Afterwards, colonies were stained with crystal violet solution and counted. Chi-square statistical analysis was performed using 
GraphPad Prism Software.  
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As shown in Figure 9, sorted cells were able to create a large number of colonies so 
cell sorting not affect the clonogenic capabilities in CT26 cell line. However, no significant 
differences were found between CD44high and CD44low populations.  
Results from PJ01 cell line are shown in Figure S3 (Annex) whereas MC38 isolated 
cells were not able to form any visible colony. It should be emphasised that sorting is a quite 
stressful procedure for cells and not all cell lines are capable to bear it. After few days, 
sorted MC38 cells were not attached to the plate at all, indicating they were probably dead 
(data not shown). A few number of small colonies of this cell line were initially detected but 
after one week, there were no colonies anymore. In PJ01 (Figure S3), CD44+ population 
seems to form more number of colonies than its CD44- counterpart but no significant 
differences were found. Indeed, results are not very reliable since the colonies were too big 
after the incubation and to count accurately. This indicates that PJ01 colonies were able to 
grow faster than CT26 ones.  
Another way to analyse the colony formation capability, is to perform a limiting 
dilution assay. This assay consists of diluting the cell suspension to get a density as low as 1 
single cell can be added in a 96-well plate. FACS facilitates the task so just 1 cell per well 
instead of thousands. Cells were sorted using anti-CD44 antibodies and the plates were 
incubated for 2 weeks in order to allow the colonies to grow. If the sorted cells have the 
intrinsic characteristic to grow on their own, cells form a visible colony. Results for these 
assays are shown in Figure 10.  
 
 
 
 
 
 
 
 
 
 
 
 Figure 10. Results of the limiting dilution assays after sorting the cells by cell sorting in PJ01 and MC38 cell lines. Cells were 
incubated with anti-CD44 antibodies and living cells were selected by 7-AD exclusion and Annexin V staining. High CD44-
expressing cells (CD44+) and low CD44-expressing cells (CD44-) were sorted using a cell sorting flow cytometer and 1 single cell 
was added per each well in a 96-well plate. Cells were incubated for 2 weeks and colonies were counted. The results are shown as 
histograms. Up histograms show the percentage of total colonies found in a 96-well plate and down histograms show the 
percentage of big and small colonies in the colonies formed. 
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Two different types of colonies were found: big colonies which even grew in several 
cell layers and small colonies which were composed by few cells growing together. So the 
percentage of these big colonies was quantified in reference to the total of colonies found. 
As shown in Figure 10, PJ01 CD44high-expressing cells were able to form more colonies than 
CD44low-expressing cells. Regarding the size of the colonies both sorted cell populations 
formed the similar rate of big colonies. MC38 cell line hardly grew in colonies and a very few 
was found. However, results shown in PJ01 cell line suggest that CD44 high-expressing cells 
form higher colony number although sorting protocol for this cell line must be optimised in 
order to improve the cell culture viability. CT26 was unable to follow the protocol due to a 
technical issue. 
Regarding the differentiation assay, same settings than in the clonogenic assay were 
used and the same populations (CD44high and CD44low) were isolated by cell sorting. We 
wanted to know if isolated CD44high population had the capability of differentiation, that is, if 
it was able to regenerate the CD44low population after the sorting. As previously described, 
CD44 is considered as a CSC-related marker (Dotse et al, 2014) but our results are not 
conclusive on this aspect. So the CD44high and CD44low- expressing populations were isolated 
and incubated for 2 or 7 days. If the hypothesis is true, high-expressing population should be 
able to differentiate into low-expressing population and reproduce the parental culture. On 
the other hand, if CD44low population is not a CSC-like population as it was described, it 
would not be able to generate the CD44high population on the same conditions.  
Results of these experiments are shown in Figure 11 for CT26 and PJ01 cell lines. 
MC38 cells, like in the previous experiments, were not able to resist the sorting procedure. 
In this case, PJ01 was unable to either. After one week, cells were not attached anymore to 
the plate and the subsequent analysis of cell viability using Annexin V and 7-AAD staining 
revealed that, indeed, almost all the cells were dead.  
As shown in Figure 11, after 48h both CD44high and CD44low-expressing cells have 
almost the same expression of CD44 in CT26 cell line. Both populations seem to be able to 
reconstitute its counterpart in 48h. The same data are shown in histograms in which a slight 
displacement of maximum peak was found, which would indicate that CD44high cells express 
indeed more CD44 than CD44low. After 7 days, differences become bigger. CD44high 
population shows slow growth in comparison with CD44low (data not shown) and also, they 
express more CD44. Regarding PJ01, CD44low-expressing cells seem to express more CD44 
after 48h of incubation than CD44high.  Nevertheless, a few number of CD44low cells were 
alive after sorting and this fact can distort the results. Actually, CD44high-expressing cell 
culture looked better than CD44low-expressing cells. All these results show in general that in 
PJ01, CD44 seem to select a cell population which exhibit characteristic associated to CSCs. 
However, in CT26 and MC38 cell lines is still unclear their relevance as a CSC marker. 
 
35 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
4.4 – USE OF PLACLITAXEL AND DOXORUBICIN TO ENRICH CSC POPULATION 
In addition to self-renewal and differentiation, CSCs have been described as highly 
chemoresistant cells. In order to see if drug treatment can enrich the CSC population and 
therefore, confirm the validity of some of the markers analysed, paclitaxel (PTX) and 
doxorubicin were used. These drugs are widely used in cancer chemotherapy and in 
Figure 11. Analysis of the differentiation capability of CD44
high
-expressig and CD44
low
-expressing cells in CT26 and PJ01 
cells. Cells were incubated with anti-CD44 antibodies and sorted according to CD44 expression. Living cells were selected by 
7-AAD exclusion and Annexin V staining. CD44 10%-top and low-expressing cells were collected in 24-well plates with 
complete DMEM media and were incubated for 2 or 7 days. After the incubation, cells were trypsinised and CD44 expression 
was analysed again by flow cytometry. Results are shown as dot plots and histograms. 
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particular, different formulations of these compounds against advanced colorectal cancer 
(Sam et al., 2010). 
First, the half maximum inhibitory concentration (IC50) for PTX and doxorubicin were 
analysed in CT26, MC38 and PJ01 cell lines. MTT assay was used as described in 3.2.5 
Materials and Methods. Results of these assays are shown in Figure 12 and Figure S4 
(Annex). 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
The MTT results for doxorubicin are shown in Figure 12 while the results for PTX are 
shown in the Figure S4 (Annex). All the data are summarised on the Table 2. Regarding PTX, 
IC50 was not easy to find so the data in the table show the concentrations at which cell 
proliferation was the 50% of the control proliferation. 
Figure 12. Effects of doxorubicin in CT26, MC38 and 
PJ01 cell lines. 5.000 cells were incubated with different 
Doxorubicin concentrations for 48h and afterwards, MTT 
assay was performed. Cells were incubated for 1h with 
MTT. After the incubation with MTT, cells were spun 
down for 30’ at 2.850 xg and resuspended in DMSO in 
order to dissolve the formazan crystals. Absorbance was 
measured at 540 nm using a spectrophotometer. Results 
are shown as histograms which represent the relative 
proliferation in comparison with control cells incubated 
without drugs. 3 replicates were done per each drug 
concentration. 
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 CT26 MC38 PJ01 
Doxorubicin 
(IC50) 
0.25 µM 0.5 µM < 0.125 µM 
PTX 
(IC50) 
0.125 - 5 µM - 0.125 - 2 µM 
As shown in the table, IC50 for doxorubicin was correctly determinated in CT26 and 
MC38 cell lines. PJ01 cells were not able to proliferate above the 50% even at concentrations 
of 0.125 µM in comparison with the proliferation of the control.   
 
 
 
 
 
These approximated values are in concordance with those found in the bibliography 
(Sam et al., 2010). Once IC50 were calculated in each drug and cell line, these concentrations 
were used in order to enrich the CSC population. Drug concentrations around the IC50 were 
used to this aim.  
As above described in 3.2.5.2 Materials and Methods, cells were incubated with 
different drug concentrations and CSC-related markers were analysed by flow cytometry. 
Results of CT26 cell line are shown in Figure 13 and Figure S.5 (Annex) show them in more 
detail. Results for MC38 cell line are shown on the Figure S.6 (Annex). 
Once more time, maximum peak displacement indicates that one specific marker is 
express in a higher amount. As shown in Figure 13, CD44 expression is increased slightly 
after the drug treatment but almost all the drug concentrations tested produce the same 
fluorescence variation. The same results were obtained for CD166 expression. Some 
problems were found regarding the analysis of CD166 treated with 1 µM of doxorubicin, so 
the histogram for this one is missed. Nevertheless, as shown the drug treatment increases 
the CD166 expression in all case but again, no differences were found between different 
treatments.  
Regarding transcription factors, some differences were found. Nanog and Oct3/4 
expression were increased in accordance with the drug concentration; the much drug 
concentration was increased, the much fluorescence measure was detected. Differences 
between different drug concentrations for Sox2 are not so clear but the drug treatment 
increase the Oct3/4 expression for certain. 
MC38 results are shown in the Annex and they are quite similar to the found in CT26 
cell line. The CD44 expression hardly increases between different drug concentrations but it 
does increase in comparison with the control one.  Transcription factors expression seems to 
increase according to the drug concentration.  
 
Table 2. Summary of the 
results of MTT assays. 
Results of the IC50 for 
doxorubicin and PTX in 
CT26, MC38 and PJ01 cell 
lines.  
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Figure 13. Analysis of transcription factor and extracellular CSC-related markers after treatment with different 
concentrations of doxorubicin. 100.000 cells were incubated with 0.25, 0.5 or 1 µM of doxorubicin for 48h and afterwards, 
cells were stained with anti-CD44, anti-CD166, anti-Nanog, anti-Oct3/4 and anti-Sox2 antibodies as indicated in Materials and 
Methods. Results are shown as different histograms; each peak represents a different drug concentration as indicated. As anti-
CD166, Nanog, Sox2 and Oct3/4 antibodies are conjugated with the same fluorophore, so different tubes were used for the 
analysis but anti-CD44 was added in all of them in order to see differences between replicates.  
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4.5 – DEVELOPMENT OF CHEMORESISTANT CELL LINES AND ANALYSIS OF THEIR CSC-
RELATED CHARACTERISTICS 
Since identification of CSCs using extracellular markers was a bit tricky, we were 
interested in knowing if CSC cell culture was feasible. As already discussed, chemoresistance 
has been related to CSC characteristics. In human colorectal cancer, some authors have 
found evidence that chemoresistant cell lines show CSC-related features being a good 
approach to study them (Bose et al, 2011). New cell lines were generated which were able to 
grow in presence of drugs.  
A protocol used for years was followed in order to generate chemoresistant cell lines 
(Yang et al, 2006). This protocol is summarised in Figure S7 (Annex). Briefly, cells were 
incubated with a sub-lethal drug concentration for some days, depending on the cell line, 
and then, cells were kept on fresh medium without drug in order to allow them to grow 
again. When surviving cells were able to proliferate reaching the confluence, cells were 
treated again. The same procedure was performed for at least three weeks or until cells 
were able to grow easily in drug-containing medium. When cells were able to grow under 
these conditions, the drug concentration was increased and the same procedure was 
repeated. The drug concentration was increased progressively until reaching clinically 
relevant doses.  
6 cell lines chemoresistant to doxorubicin and PTX were generated: CT26-0,5 DoxR, 
CT26-1 DoxR, CT26-2 DoxR, CT26-1 PTXR, PJ01-50n DoxR and MC38-50n DoxR as it is 
indicated in Table S1 (Annex). 
Chemoresistant CT26 cell lines were relative easier to generate in comparison with 
PJ01 and MC38 cell lines. These cell lines were more susceptible to doxorubicin than CT26 as 
previously shown and lower concentrations (50 nM of doxorubicin) were tested in order to 
create a chemoresistant cell line in these cell lines. When the concentration was optimised, 
some cells were able to proliferate despite the drugs and chemoresistant cell lines were 
generated. After generation of these cell lines, chemoresistance was tested by MTT assay as 
previously described as well as cross-chemoresistance. Results are shown in Figure 14.  
Only CT26-0,5 DoxR and CT26-1 PTX cell lines were tested due to they were the first cell lines 
generated. Doxorubicin chemoresistant cell lines were able to grow better than WT cell lines 
with statistically significant differences; although PTX chemoresistant cell line was resistant 
in drug-containing medium, no significant differences were found. 
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As shown Figure 12, MTT assays using PTX did not work as usual and no proliferation 
differences were found so this fact might explain these results. Also, no cross-
chemoresistance was found between doxorubicin chemoresistant cell lines and PTX, and vice 
versa except for 0.1 µM of PTX in doxorubicin resistant cell line and 1 µM of doxorubicin in 
PTX resistant cell line. 
CSC-related markers were analysed in the CT26-0,5 DoxR and CT26-1 PTXR cell lines. 
Results were shown in Figure 15. As shown in Figure 15 because of the maximum peak 
displacement, doxorubicin and PTX seems to enrich all the CSC-related population. These 
results looks to indicate that a long-term exposition could increase the CSC-related features 
but further analysis of these chemoresistant cell lines must be done.  
 
 
 
Figure 14. Results of the MTT assays in chemoresistant cell lines generated. MTT assays were used in order to analyse the 
differential proliferation of the chemoresistant cell lines in comparison with the wild type ones. Cells were incubated with 
different drug concentrations for 48h. After the incubation, MTT assays were performed as indicated in Materials and 
Methods.  
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4.6 – DEVELOPMENT OF 3D CELL CULTURES IN ORDER TO GET A CSC-ENRICHED CELL 
CULTURE 
In order to get a cell culture enriched in CSCs to test different antitumor therapies 
against CSCs, a 3D cell culture protocol was optimised. It has been descripted that the 
architecture of the cell culture as well as the lack of oxygen and other vital nutrients can 
influence the CSC population (Yang et al, 2012). 
As described in 3.2.7 Materials and Methods, the hanging drop method was used to 
develop 3D cell cultures. Briefly, cells were mixed with a medium containing methylcellulose 
in order to increase the surface tension. The mixture was added as drops on the inner side of 
a Petri dish lip so when the lid is closed, cells rounded down towards the bottom of the drop 
and, being together, started to grow in a 3D cell culture known as spheroid. Spheroids were 
collected in a 96-well plate and trypsinised in order to analyse the extracellular markers.  
Results of these experiments are shown in Figure 16.  
The peak displacements indicate that 3D culture is enriched in CD44-expressing cells 
in comparison with 2D cell culture in CT26 cell line; however, PJ01 and MC38 3D culture did 
not show the same enrichment for CD44. Regarding CD166, 3D cultures did not show big 
differences although the expression in the expression of CD166 was slightly higher indeed.  
 
Figure 15. CSC-related markers on the chemoresistant cell lines. CT26-0,5 DoxR and CT26-1 PTXT cell lines as well as CT26 
WT were incubated with anti-CD44, anti-CD166, anti-Nanog, anti-Oct3/4 and anti-Sox2 antibodies as the intracellular and 
extracellular protocol indicate in Material and Methods . ALDH activity was measured in these cell lines too. Results of these 
experiments are shown as histograms where peak displacements indicate a higher expression of the marker.  
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4.7 – ANALYSIS OF THE INFLUENCE OF GRANZYME-A IN THE EXPRESSION OF CSC-RELATED 
MARKERS 
The final aim of this study is to analyse the role of Granzyme-A in the emergence of 
CSCs during inflammation-associated colorectal cancer in mice. Our lab has optimised the 
protocol for developing colorectal carcinomas in the C57Bl/6 mice using the AOM/DSS 
protocol. As described in 3.2.8 Materials and Methods, mice GzmA -/- (Gzm-A-deficient 
mice) and WT mice were treated following the AOM/DSS protocol. After treatment, mice 
were killed and tumours were extracted from the distal colon. Tumours were digested and 
individual cells were obtained in order to analyse the CSC-related markers. In this case CD44, 
CD166 and transcription factor expression were analysed as well as the ALDH activity. 
Results are shown in Figure 17.  
It is a bit difficult to analyse the differences in the image but briefly, no differences 
were found among GzmA -/- tumours and WT tumours. All maximum peaks are around the 
same fluorescence measure and in the cases in which any peak is displaced, no correlation 
was found. For example for CD44, red and blue peak are displaced from the others indicating 
a low expression of CD44; however, red peak corresponds to a WT tumour while blue peak 
correspond to a GzmA -/- tumour.  
Figure 16. CD44 and CD166 expression in 3D cell culture of CT26, MC38 and PJ01 cell lines. Cells were grown in 3D 
culture using the hanging drop method. CD44 and CD166 expression was analysed by flow cytometry and compared with 
cells in 2D cell culture. Results are shown in histograms.   
43 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 17. Analysis of the influence of GzmA in the presence of CSCs. GzmA-deficient (GzmA -/-) and WT mice were 
treated with DSS/AOM protocol as described in Material and Methods. After treatment, mice were killed and tumours 
were extracted from the distal colon. Tumours were digested using a Digestion Kit as indicated in Material and Methods 
and individual cells were obtained. Then cells were stained using anti-CD44, anti-CD166, anti-Nanog, anti-Oct3/4 and anti-
Sox2 antibodies and ALDH activity was measured by ALDEFLUOR kit and flow cytometry. Results are shown as histograms.  
Red and black histograms show the data from 2 independent WT tumours and green and blue ones show the data from 2 
independent GzmA -/- tumours. 
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5. Discussion 
 
In this study CD44, CD166, Nanog, Oct3/4 and Sox2 expression has been analysed in order to 
identify a CSC population in mouse cell cultures and then, to use these protocols to analyse the 
influence of Granzyme-A in the development of colorectal cancer in mouse model.  
Our first goal was to analyse the expression of these markers in cell cultures. Few 
studies have been published regarding CSCs in mouse colorectal cancer cell lines. 
Transcriptome and proteome analysis has been described in order to characterise CT26 cell 
line and CD44 and Oct3/4 expression was highly found (Castle et al, 2014). Our results in 
CT26 cells are in agreement with these works as a major CD44 positive population was 
found. Expression of CD44 was not homogenous in CT26 cell line indicating that there were 
different subsets based on CD44 expression. CD166 and Nanog positive population were also 
identified in this cell line; however, no Oct3/4 and Sox2 positive population was found. 
Nanog is a protein which is able to be expressed in the cytoplasm and inside the nucleus 
while Oct3/4 and Sox2 are not described as cytosolic proteins (Amini et al, 2014), so our first 
hypothesis was that our protocol staining was only working for cytosolic proteins. However, 
this hypothesis was discarded due to the positive results found in the other cell lines. All 
these transcription factors have been described as stemness markers and their expression 
was used to identify stem cells in normal tissues (Miyoshi et al, 2009).  They have been 
related to CSCs in human transformed cell lines but there are not articles in mouse cell lines 
(Amini et al, 2014). CD44 positive cells were found in PJ01 and MC38 cell lines but its 
expression was more homogenous than in CT26 cell line. Nanog positive cells were also 
identified in MC38 and PJ01 cell lines but this population was especially higher in PJ01 cells. 
A huge Oct3/4 positive population was found in PJ01 cell line and a smaller well-
distinguished positive population was identified in MC38 cells. Regarding PJ01, obviously 
there is no article in the literature as it is a cell line generated in our lab. However, these 
differences between cell lines regarding CSC-related markers can be related with their 
sensitivity to antitumor drugs as it has been shown in human colorectal cancer cells as well 
as their capability to create colonies (Dolgova et al, 2014). These results are in accordance 
with the IC50 calculated in this study. CT26 and MC38 cell lines showed a higher expression 
of CD44, CD166 and ALDH activity than PJ01 and those cell lines showed a higher resistance 
to doxorubicin as the IC50 values showed.  
It is difficult to find studies that analyse CSC presence in mouse cell lines and usually, 
analysed the expression of these proteins using qPCR or other genetic tools (Castle et al, 
2014). Correlation between two or more CSCs-related markers has been proposed as the 
best way to find and isolate the CSC population in tumours, and in particular, in CRC tumours 
(Zhou et al, 2016). Some studies described CD44 positive cells as CSCs regarding their 
abilities to generate bigger and more aggressive tumours in mice after transplantation 
(Jinushi et al, 2011). This population is supposed to be enriched in CSCs but functional 
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analysis must be performed in order to confirm it. CSCs are defined by their functional 
features such as self-renewal, differentiation and chemoresistance so other characteristics 
should be analysed like ALDH and ABC transporter activities. These activities have been 
used to identify CSCs as well as normal stem cells so they were tested in order to find a 
correlation between them and CD44, CD166, Nanog, Oct3/4 and Sox2 expression. Our 
results show that a higher activity of ALDH correlates with a higher expression of CD44, 
CD166 and transcription factors. However, the Hoechst 33342 low-retention population was 
not correlated with a high expression of these markers. Side population, identified as a 
population with low retention of Hoechst 33342, has been used for years to identify CSCs 
(Dean, 2009). Some possibilities were considered to explain our results. It could be that the 
side population was an apoptotic population that retained less dye decause of DNA 
degradation. ALDH buffer containing efflux pump inhibitors was used in order to reveal this 
problem. The use of this buffer blocks the ABC transporter activity so side population can be 
identified easily. As shown in Results, the side population was identified when ALDH buffer 
was not used. Also, 7-AAD and Annexin V were used to select living cells so we concluded 
that side population was identified properly but it does not correlate with the CSC-related 
markers and it might not be a suitable approach to identify CSCs in mouse cell lines.  
 
In order to analyse other CSC features like clonogenic and differentiation potential, 
cell sorting was used. Intracellular markers such as Nanog or Oct3/4 cannot be used for 
these assays since the protocol fix the cells. Few ALDH and CD166 positive cells were found 
in the three cell lines so cell sorting would compromise cell viability during the procedure if 
these markers were used. So finally, CD44 was chosen to sort cells and different assays were 
performed in CD44 high- and low-expressing cells. On one hand, clonogenic and limiting 
dilution assays were performed in order to analyse the ability of sorted population to grow 
and form colonies. On the other hand, differentiation assays were performed in order to 
analyse if sorted populations were able to regenerate the parental culture. Both features 
define CSCs. 
Clonogenic assays showed that CD44 high-expressing cells were not able to form 
more colonies than low-expressing cells. However, limiting dilution assays showed a 
significant increase in the number of cell clones formed by the high-expressing cells. These 
apparently contradictory results can be explained regarding the procedure of both assays. 
Clonogenic assays evaluate the clonogenic capabilities adding hundred cells per well. The 
number of cells per well is so low that they are supposed to be isolated from the others and, 
if they are CSCs, they must be able to grow on their own. However, CSCs have been 
described to be able to influence to other cells through releasing soluble factors such as IL-8 
or other growing factors. These factors activate proliferation signalling pathways like Wnt 
pathway (Pattabiraman et al, 2014)(Li et al, 2012). So, although cells were indeed isolated 
from the others in clonogenic assays, soluble factors might be present in the medium and 
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allow differentiated cells to grow. Only physical separation would be suitable for isolating 
CSCs and evaluating clonogenic capabilities in cell cultures as limiting dilution assays do. 
These assays add 1 single cell per well and so, cells are completely isolated from the other. If 
they are CSCs, after few weeks they will form a colony. Results for this assay showed that 
CD44 high-expressing cells were able to form more colonies than CD44 low-expressing cells 
indicating that this population was enriched in CSCs.  
Two types of colonies were found in limiting dilution assays regarding the size. CSCs 
show a slower proliferation rate than mature cancer cells and proliferation tests proved that 
low proliferative cells did show CSC features such as chemoresistance or higher tumour 
incidence in mice (Dolgova et al, 2014). Large colonies might come from a specific CSC with 
higher differentiation capability but no differences were found among sorted populations 
regarding the number of big colonies. Also, no articles were found about this so further 
analysis must be done to unravel it.  
Another feature that defines CSCs is the differentiation ability. Cell sorting was used 
in order to analyse this ability.  However, both sorted populations were able to reconstitute 
the parental culture although some differences were found regarding CD44 expression and 
cell viability. These results can be explained in some different ways. On the one hand, cell 
sorting is usually used for isolating well-distinguished populations with at least 2 or 3 orders 
of magnitudes so maybe the sorting might not work properly on this isolation. Nevertheless, 
other authors were able to isolate and observe differences in colony formation ability 
between high and low-expressing cells for one or two different markers so a priori this 
should not be a problem (Zhou et al, 2016). Although cell sorting would work properly, some 
cells can escape to the sorting and they might grow and proliferate so finally, cell culture 
would be regenerated. However, during long-term incubation, differences were found and 
CD44low population was not able to grow as well as CD44high population did. It should also be 
noted that in both cell “types”, a high number of 7-AAD and Annexin V positive cells were 
detected after one week indicating that a large amount of cells were dying and so, results 
might be distorted.  
 
Some authors have claimed that cell line cultures could not be a good approach to 
analyse and isolate CSCs and propose primary cell culture or different culture medium as 
better options. In this study, drug treatment, chemoresistant cell lines and 3D cultures were 
used to try to get a CSC-enriched cell culture.  
To overcome chemoresistance is one of the main goals to achieve in colorectal 
cancer research and CSCs have been hypothesised as the main responsible of this process. 
Drug treatments have been used in order to enrich CSC population in human cell but there 
are no studies regarding mouse cell lines (Choi et al, 2011) (Li et al, 2015). These papers 
show how drug treatments increase the Notch and Wnt signalling pathway, a pathway 
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related to CSCs characteristics. Doxorubicin is an anticancer drug which acts as a DNA 
intercalating agent and its cardiac toxicity is a serious limitation for its clinical use besides 
haematological and gastrointestinal disorders (Gianni et al 2001) whereas PTX mechanism of 
action involved interference with the normal breakdown of microtubules during cell division. 
These drugs were used in order to enrich CSCs populations and results showed that a higher 
expression of all CSC-related markers was found in cells treated with drugs. Similar results 
were found in human colorectal cancer cell lines although other CSC-related markers were 
studied (Dallas et al, 2011).  
Chemoresistant cell lines were developed in order to analyse the influence of a long-
term drug exposure in CSC-related markers. All markers were expressed in a higher amount 
in chemoresistant cell lines except for and Nanog or Oct3/4 in PTX-resistant cell line.  
3D cell culture is a new approach to imitate real tumours and it is supposed to be a 
better in vitro model than typical cell culture in 2D. Some studies show that 3D cell culture 
can enrich CSC population (Chen et al, 2012); however, no all of them have shown an 
enrichment in CSC-related extracellular markers. Our results show that only CD44 was 
enriched in CT26 cell line whereas the rest of cell lines showed a similar CD44 expression and 
even a decrease of CD44 expression. However, CD166 showed a slight increase in 3D 
cultures. CD44 and CD166 are adhesion proteins which mediate the interaction among cells 
in tissues. However, in cancer they have been described as key molecules for migration and 
metastasis processes. Cells in spheroid culture grow as a tumour mass in which cells are 
strongly attached between them and so, nutrients such as oxygen or glucose might increase 
the expression of these molecules. 
 
Finally, the influence of Granzyme-A in CSC-related marker expression was analysed. 
Tumour environment has been described as a key target in immunotherapies. Molecules 
such as TNF-α or IL-1B are mediators of chronic inflammation which has been related to 
poor prognosis and tumour development. GzmA has a key role in the development of 
colorectal cancer as a pro-inflammatory molecule and its presence is related with a higher 
tumour incidence in mice as our lab has shown (data not shown). CSCs might be behind this. 
However, our preliminary results did not show any difference among tumours from GzmA -/- 
and WT mice. It should be noted that some differences were found in comparison with 
previous experiments of the DD/AOM model. Usually GzmA -/- mice have less inflammation 
than WT mice. However, in this experiment a high inflammatory response was not found in 
WT mice as usual. Also, GzmA -/- mice used to have less tumour incidence than WT mice but 
in this experiment, they have around the same number of tumours than WT and similar size. 
All these data suggest that this experiment might not work properly and further analysis 
must be done in order to clarify if GzmA is not related to the emergence of the CSC 
population. 
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6. Conclusions 
 
As a result of all the data analysed in the current study, the following conclusions were 
extracted: 
- The high expression of CD44 and CD166 extracellular markers correlates with the 
expression of the transcription factors Nanog, Oct3/4 and Sox2 in CT26, MC38 and 
PJ01 cell lines 
- High ALDH activity is related with CD44, CD166 and Nanog, Oct3/4 and Sox2 
expression. 
- Hoechst 33342 exclusion test was unable to identify a side population with a 
correlation with the other CSC-related markers.  
- CD44 high-expressing cells were able to form more clones than CD44 low-expressing 
cells. 
- Limiting dilution assay is more effective than clonogenic assay to analyse proliferating 
capabilities.  
- Doxorubicin and PTX drug treatments enriched the CSC population. 
- The expression of CSC-related markers was increased in chemoresistant cell lines. 
- 3D cell cultures were optimised for the three cell lines and enrichment was found in 
CD166 expression and CD44 expression was increase only in CT26 cell line. 
- DSS/AOM-induced colorectal tumours from GzmA-deficient mice did not show a 
higher expression of CSC-related markers in comparison with tumours from WT mice.  
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6. Conclusiones 
 
Como resultado de todos los datos analizados en este estudio, se han extraído las siguientes 
conclusiones: 
- La alta expresión de CD44 y CD166 mostró correlación con una alta expresión de los 
factores de transcripción Nanog, Oct3/4 y Sox2 en las líneas celulares CT26, MC38 y 
PJ01.  
- La alta actividad de la enzima ALDH mostró correlación con una elevada expresión de 
CD44, CD166 y de los factores de transcripción Nanog, Oct3/4 y Sox2.  
- El ensayo de exclusión de Hoechst 33342 no fue capaz de identificar una población 
lateral que correlacionara con una alta expresión del resto de marcadores analizados 
relacionados con CSCs.  
- La población CD44high en la línea celular CT26 fue capaz de formar más clones que la 
población CD44low. 
- El ensayo de dilución límite es más efectivo para analizar las capacidades 
proliferativas de una línea celular.  
- Los fármacos doxorrubicina y PTX fueron capaces de enriquecer la población positiva 
para los marcadores relacionados con CSCs analizados.  
- Las líneas quimioresistentes desarrolladas en este estudio mostraron un incremento 
de los marcadores relacionados con CSCs analizados. 
- Se optimizaron los cultivos en 3D para las líneas celulares utilizadas en este estudio y 
se encontró un ligero aumento de la expresión de CD166 en las 3 líneas celulares 
analizadas y sólo de CD44 para la línea CT26. 
- Los tumores obtenidos en el protocolo de generación de cáncer colorectal inducido 
por DSS/AOM en ratones deficientes de Granzima-A no mostraron diferencias en 
comparación con los tumores obtenidos de la misma manera en ratones WT. 
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